Paper1125
The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.
Davis SS and 2 others. Biorheology, 1975. Cited by 15 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus. Papers, record 1125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1125
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mucus | Major topic |
| Sulfhydryl Compounds | Major topic |
| Animals | |
| Calcium | |
| Cervix Mucus | |
| Elasticity | |
| Gastric Mucosa | |
| Hydrogen-Ion Concentration | |
| Models, Biological | |
| Rheology | |
| Swine | |
| Viscosity |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28405161 | Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians. | Int J Chron Obstruct Pulmon Dis | 2017 | https://conductscience.org/library/papers/28405161 | PubMed |
| 26244017 | Positioning new pharmacotherapies for COPD. | Int J Chron Obstruct Pulmon Dis | 2015 | https://conductscience.org/library/papers/26244017 | PubMed |
| 25125976 | Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease. | Int J Chron Obstruct Pulmon Dis | 2014 | https://conductscience.org/library/papers/25125976 | PubMed |
| 4031059 | Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones. | J Clin Invest | 1985 | https://conductscience.org/library/papers/4031059 | PubMed |
| 115900 | Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species. | J Clin Invest | 1979 | https://conductscience.org/library/papers/115900 | PubMed |
| 33658 | Enhancement of the viscosity of mucin by serum albumin. | Biochem J | 1978 | https://conductscience.org/library/papers/33658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1125
GET https://conductscience.org/api/papers/v1/1125/authors